Skip to content

Clinical trials

Observational Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Observational Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20043
20052
20065
20073
20084
20095
20104
20113
20125
20135
20146
20157
20164
20174
20186
20198
202014
20218
20228
20233
20244
20251
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76
Unknown status24
Recruiting12
Terminated6
Not yet recruiting3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Boehringer Ingelheim4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Brigham and Women's Hospital3
GlaxoSmithKline3
Karolinska Institutet3
Abbott Medical Devices2
Celgene2
Inari Medical2
Odense University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism124
Atrial Fibrillation21
Venous Thromboembolism21
Thrombosis18
Pulmonary Embolism16
Venous Thrombosis15
COVID-1912
Hemorrhage11
Cardiovascular Diseases10
Stroke9

Trials

Showing 76 to 100 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.